(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

UROVANT SCIENCES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

UROVANT SCIENCES

ST13

US500000079331299

Class

5, 38, 41, 44

Filing

79331299

Registration

6938285

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

03/14/2025

Trademark type

Combined

Nice classes

5, 38, 41, 44

Filing date

10/26/2021

Registration date

01/03/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/03/2023

Last transaction

03/14/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

27

Owner location

CH

Examiner

WELCH, KATHERINE

Law office

O20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "UROVANT". The letter "A" contains a wavy line design. Below the "VANT" is the word "SCIENCES" in a smaller font.

Holders and representatives

Holders

Urovant Sciences GmbH

Representatives

Jeffrey R. Cadwell Dorsey & Whitney LLP

Technical classification

Nice Classes

Class 5Class 38Class 41Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and biological preparationsfor the prevention of urologicalurinary tract systemsreproductive organ diseases and disorders; pharmaceutical preparations for human use for the prevention of urologicalurinary tract systemsreproductive organ diseases and disorders; biological and pharmaceutical preparations for medical and therapeutic use for the prevention of urologicalurinary tract systemsreproductive organ diseases and disorders; pharmaceutical preparations for human use for the prevention of medical conditionsurologicalurinary tract system and reproductive organ disorders; pharmaceutical preparations for human use for the treatment of medical conditionsurologicalurinary tract system and reproductive organ disorders; biological and pharmaceutical preparations for medical and therapeutic use for the prevention of medical conditionsurologicalurinary tract system and reproductive organ disorders; biological and pharmaceutical preparations for medical and therapeutic use for the treatment of medical conditionsurologicalurinary tract system and reproductive organ disorders

Class 38

Providing online chat rooms for transmission of messages among computer users concerning disease preventionidentification and treatment education relating to medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases; peer-to-peer network computer serviceselectronic transmission of audio sequencesvideo sequences as well as other data and documents among computerssuch audio sequencesvideo sequences and other data and documents all relating to preventionidentification and treatment of medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases; providing online chat rooms for transmission of messages among computer users concerning the fields of biological and pharmaceutical preparations; peer-to-peer network computer serviceselectronic transmission of audio sequencesvideo sequences as well as other data and documents among computerssuch audio sequencesvideo sequences and other data and documents all relating to the fields of biological and pharmaceutical preparations

Class 41

Providing educational information in the academic fields relating to preventionidentification and treatment of diseases related to medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases for the purpose of academic study; providing educational information in the academic fields of biological and pharmaceutical preparations for the prevention of medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases for the purpose of academic study; providing educational information in the fields of preventionidentification and treatment of medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases for medical purposes; educational and entertainment servicesproviding motivational and educational speakers in the fields of medicinehealthpharmaceuticalsdisease and disorder identificationtreatment and prevention; providing online non-downloadable articles in the fields of medicinehealthpharmaceuticals and disease and disorder identificationtreatment and prevention

Class 44

Provision of health information and medical informationall for treatment and diagnostic purposes; provision of information concerning the diagnosticprophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseasesconditionsdisorders and pathologies; providing health care advice and medical advice in the fields of preventionidentification and treatment of medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases; providing medical and physical health advice in the fields of biological and pharmaceutical preparations for medical use

Publications

History of USPTO decisions and trademark events.

45 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/13/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/03/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/03/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/03/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/03/2024

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

04/12/2024

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

04/12/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/08/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

04/08/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/08/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/08/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/08/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/08/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/23/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/17/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/20/2023

FIMP

FINAL DISPOSITION PROCESSED

04/20/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/03/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

03/18/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/03/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/03/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/25/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/18/2022

PUBO

PUBLISHED FOR OPPOSITION

10/18/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/28/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/12/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/01/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/31/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/31/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/30/2022

RFNT

REFUSAL PROCESSED BY IB

04/18/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/28/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/28/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/28/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/28/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/28/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/28/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/25/2022

RFRR

REFUSAL PROCESSED BY MPU

03/25/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/19/2022

CNRT

NON-FINAL ACTION WRITTEN

02/18/2022

DOCK

ASSIGNED TO EXAMINER

02/11/2022

MAFR

APPLICATION FILING RECEIPT MAILED

01/25/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/21/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/20/2022

Continuous trademark protection

Get notified about every new filing that threatens UROVANT SCIENCES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.